Table 5 Characteristics of diabetic patients with point substitution mutations in the pre-C/C, BCP, and X regions of the HBV genome
Accession No | Patient no | Sex (M/F) | Age (year) | OD HBsAg ELISA | Pre-C/C mutation | Pre-C/C nt (1814–2452) | X mutation (1374–1838) | BCP mutation (1742–1849) |
|---|---|---|---|---|---|---|---|---|
OK382075 | 63 | F | 61 | 0.1 | G29D, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T |
OK382076 | 65 | F | 72 | 0.14 | G29D, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T |
OK382077 | 66 | M | 42 | 0.14 | G29D, S64A, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T |
OK382078 | 69 | F | 47 | 0.15 | C7R, G29D, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T, T1832C |
OK382079 | 71 | F | 43 | 0.166 | G29D, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T |
OK382080 | 80 | F | 60 | 3.14 | W28*, G29D, S50A, S78T, T96I, A109T, S116G, T120S, I145L, A160P | G1896A, G1899A | I127L | A1727G, A1752C |
OK382081 | 82 | F | 96 | 3.82 | W28*, S50T, Y67F, E93D, A109V, S116G, N121T, M122V, T143I, P164T | G1896A | I127L | A1752C, A1775C |
OK382082 | 83 | F | 66 | 3.4 | W28*, C77G, S78T, A109T, A160G | G1896A | T1758C, C1773T, A1775G | |
OK382083 | 84 | F | 42 | 3.1 | E69N, G103V | I127T, K130M, V131I | T1753C, A1762T, G1764A, | |
OK382084 | 85 | F | 73 | 2.6 | V17F, W28*, G29D, S50T, F53Y, S78T, G103A, E106Q, L113Q, I145L, T176C, R180Q, P185S | G1896A, G1899A | I127L | A1752C |
OK382085 | 86 | M | 75 | 0.246 | G29D, E93D, A109V, N121T, M122A, I145L, P159Q, P164T | G1899A | I127T, K130I, V131L | T1753C, A1762T, G1764T, C1766G, C1773T |